KalVista Pharmaceuticals reports third quarter financial results
KalVista reported the net loss was $5.2 million for the 2018 third quarter, versus a net loss of $7.6 million for the same 2017 period. Revenue was $2.3 million for the 2018 third quarter versus $0.2 million for the prior year period. March 16, 2018